Unlocking the hidden potential of neural crest cells
Lifespan.io (LEAF) - 15-Nov-2024Toronto researchers reveal neural crest cells' hidden role in direct lineage transitions
Yuri Deigin
Co-founder and Director at YouthBio Therapeutics
Yuri is a biotech entrepreneur with a focus on early-stage translation of scientific breakthroughs into therapies. He has over a decade of drug discovery and development experience, and a track record of outlicensing products to Big Pharma.
Yuri has previously led several early-stage pharmaceutical startups, including one developing an Alzheimer's Disease therapeutic, and another startup developing small-molecule neuroprotectors for Alzheimer's, Parkinson's, and a rare pediatric disease.
Additionally, Yuri has been a vocal evangelist of epigenetic rejuvenation by partial reprogramming with Yamanaka factors since 2017.
Visit website: https://youthbiotx.com/#yuri
See also: 
YouthBio Therapeutics
- Developing rejuvenation gene therapies based on partial reprogramming by Yamanaka factors
Details last updated 02-Apr-2022
Yuri Deigin is also referenced in the following:
Longevity Summit Dublin 2023
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
New discovery: we can reprogram cells to become younger! Yuri Deigin
Yuri Deigin discusses reprogramming cells to reverse ageing
Vision Weekend Puerto Rico 2025
23-Feb-2025
Foresight Institute annual event (Old San Juan, Puerto Rico)
YouthBio Therapeutics
Developing rejuvenation gene therapies based on partial reprogramming by Yamanaka factors
Yuri Deigin | Epigenetic Reprogramming, Cryonics & COVID Lab Leak
Live Longer World podcast #17 with Yuri Deigin as a guest
Yuri Deigin News
Unveiling the future of age reversal: meet Yuri Deigin, founder of YouthBio Therapeutics
Longevity Technology - 08-Mar-2023Tissue-specific gene therapies & rejuvenating factors to extend lifespan and combat age-related diseases
Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022Some really exciting developments with quite a few in clinical trials
YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO
CISION PR Newswire - 14-Apr-2022Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line
